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1 
Executive Summary   
The measured UV radiation in full sun and in shade and how this relates to vitamin D3 
exposures for various latitudes throughout Australia is reported. Calibrated spectral and 
dosimetric measurements were employed to measure the UV radiation in the shade of 
numerous shade environments for varying solar zenith angles and seasons. This was for 
exposures to the horizontal, 45
o
 and vertical planes; as well as to specific anatomical sites 
for the solar zenith angle range of approximately 5
o
 to 80
o
 and provides a comprehensive 
data set of the vitamin D3 exposures and the damaging UV exposures. The results and 
findings are summarised as follows: 
 
• Shade environments were divided into two groups: shade with sky view of greater than 
40%; and shade with sky view of less than 40%;  
• The highest UVD3 irradiances for both global and diffuse were found to occur in the 
middle of the day; 
• There is a significant variation in the relative proportions of the UV wavelengths when 
comparing diffuse UV to global UV; 
• The average difference (15% to 20%) between the proportions of the diffuse UV in the 
global UV were at a maximum for SZA’s smaller than approximately 55o;  
• For a SZA of approximately 5o, average UVD3 irradiances were 0.67 W/m
2
 and 0.20 W/m
2
 
for global and for shade with a sky view of greater than 40% respectively; 
• Variations in cloud cover (below 8 okta) are far less likely to cause an obvious change in 
UVD3 exposure times in the shade; whereas global UVD3 exposure times will vary 
significantly depending on cloud cover and solar disc cover.;  
• Shade with a sky view of greater than 40% can be found very easily and this makes it very 
useful for the general public as the damaging UVA wavelengths are reduced more on a 
relative basis compared to the beneficial vitamin D3 wavelengths; 
• Utilising shade for UVD3 exposures can reduce total UV exposure by 37% to 58% 
compared to full sun UVD3 exposures; 
• The best time to expose the human body to UV radiation while utilising shaded 
environments with a sky view of greater than 40% for vitamin D3 synthesis is for SZAs 
less than approximately 45
o
  
• The largest variation in exposure ratios to the anatomical sites between the seasons was 
for the nose compared to full sun UVD3 exposure. The shade reduced exposures to the 
nose to approximately 38% and 63% of full sun exposures in summer and winter 
respectively.; 
• Shade can be used throughout Australia during summer and winter; However, winter 
exposure times will vary depending on the latitude; 
• This research indicates that an improved approach to optimise UV exposures for the 
production of vitamin D3 is to utilise diffuse UV under shade in and around the middle of 
the day. 
 
 
2 
Aims 
Humans need to be protected from damaging UV radiation, but they also need to be exposed 
to solar UVB so that vitamin D3 synthesis can occur. Vitamin D3 is essential to maintain 
extracellular fluid concentrations of calcium and phosphorous; hence, it is important for the 
prevention of rickets in children, osteoporosis, osteomalacia, and fractures in the elderly. 
Epidemiological data and animal studies also indicate that low blood serum vitamin D3 is 
linked to breast cancer, prostate cancer, colorectal cancer and numerous other disorders. Solar 
terrestrial UV radiation in the region of 290 to 330 nm is acknowledged as an initiator of the 
synthesis of vitamin D3 for humans as it photolyses 7-dehydrocholesterol in the human skin, 
to pre-vitamin D3, which is then converted to vitamin D3 by a heat induced process. After two 
separate hydroxylations (first in the liver, then in the kidney) the active form of the vitamin 
(i.e. 1,25(OH)2-vitamin D3) is produced (Sliney, 1994; Webb et al, 1988). Although, over 
exposure to these UV wavelengths are known to cause skin damage, pre-vitamin D3 synthesis 
generally occurs at sub-erythemal irradiances.  
 
Due to the phenomena of Rayleigh and Mie scattering in the earth’s atmosphere, there is a 
significant proportion of the solar UV present in shade due to scattered radiation. Studies on 
the levels of UV observed in the shade of different shade environments have shown that the 
relative proportions of UVA (315-400 nm) and UVB (280-315 nm) in the shade are 
significantly different to those in full sun. The relative proportions are decreased for UVA 
and increased for UVB. Therefore, in the shade there is an increase in the relative proportion 
of the biologically effective wavelengths associated with pre-vitamin D3 production in the 
body and a decrease in the biologically damaging UVA irradiances compared to full sun. 
This is significant because exposure to harmful solar UVA radiation is linked to skin cancer, 
DNA damage, macular degeneration and immunosuppression in humans. Currently, there is a 
major gap in knowledge in order to optimise the beneficial effects related to vitamin D3 
effective wavelengths compared to reducing the biologically damaging overexposure to UV 
radiation.  
 
The hypothesis for this project is that: at certain latitudes, the diffuse UV in shade may play 
an important role in providing the human body with adequate levels of UVB radiation for 
pre-vitamin D3 production without experiencing the high levels of damaging UVA observed 
in full sun. 
 
Specifically, this project aims to:  
1. Quantify the amount of pre-vitamin D3 effective UV wavelengths under different 
shade environments by undertaking extensive field work using dosimetry and spectral 
measurements;  
2. Measure the distribution of pre-vitamin D3 effective exposures over the human form 
using polysulphone dosimeters and human manikins;  
3. Quantify the effect of a latitude gradient on pre-vitamin D3 effective exposures in the 
shade.  
 
 
 
 
 
3 
Introduction 
 
The health effects of solar UV radiation vary significantly, from initiating the synthesis of 
vitamin D3 to the severe degradation of the human body. Excessive solar UV radiation 
exposure led to the premature deaths of approximately 60 000 people in the year 2000 (Lucas 
et al, 2006). It is well known that exposure to small amounts of UV radiation are beneficial 
for the human body and important in the production of vitamin D3, whereas excessive 
exposure to sunlight is known to cause skin cancer, immune suppression, DNA damage, 
erythema and sun-related eye disorders (Baron et al., 2003; Glerup et al., 2000; Terenetskaya, 
2000; Sliney and Wengraitis, 2006; Setlow et al., 1993).  
 
Solar UV radiation is acknowledged as the major provider of vitamin D3 for humans. It is 
estimated that approximately 90-95% of our vitamin D3 requirement comes from exposure to 
the sun (Holick, 1998; Holick, 2004). Terrestrial UV radiation in the 290 – 330 nm portion of 
the solar spectrum (CIE, 2006) photolyses 7-dehydrocholesterol in the human skin, to pre-
vitamin D3, which is then converted to vitamin D3 by a thermal process (Glerup et al, 2000; 
Webb et al, 1988; Webb, 1993; Webb, 2006; Grant et al, 2007). The main function of vitamin 
D3 in humans is to maintain extracellular fluid concentrations of calcium and phosphorous 
(Holick, 1997).  
 
The incident terrestrial solar UV waveband is broken into two sections: UVB (280-315 nm) 
and UVA (315-400 nm). The UVB bandwidth is less than half that of the UVA bandwidth, 
with 90-95% of the incident terrestrial solar UV radiation consisting of UVA radiation 
(Miller et al, 1998). The longer wavelength UVA radiation (greater than 330 nm) plays no 
part in the synthesis of vitamin D3 in humans. In comparison, research has shown that UVA 
plays a significant role in causing mutagenic and carcinogenic effects on human skin (Agar et 
al, 2004; Moan et al, 1999; Garland et al, 2003; Wang et al, 2001). UVA has longer 
wavelengths than UVB and thus penetrates deeper into skin. Research has shown that UVA 
radiation can stimulate melanocyte proliferation, cause abnormalities in DNA, and modify 
gene expression (Wang et al, 2001). It has been estimated that approximately 19-50% of 
UVA can reach the depth of melanocytes, whereas only about 9-14% of UVB reaches a 
similar depth (Schothorst et al, 1987; Kaidbey et al, 1979; Bruls et al, 1984). The specific 
long-wave property of UVA also allows it to penetrate most automobile, office and 
household windows, whereas UVB is blocked by window glass (Parisi et al, 2007; Kimlin et 
al, 2002; Wang et al, 2001).  
 
Various studies have also shown that the global distribution of UVA may account for much 
of the global variation in the mortality rates from melanoma, in particular the high rates at 
increased latitudes (Garland et al, 2003). Some European studies have even found a south to 
north increase in serum 25‐hydroxyvitamin D that parallels a similar gradient in the 
incidence of colorectal, breast and prostate cancers (van der Wielen et al,1995; IARC, 2008). 
However, research from the USA shows that outdoor behaviour and obesity are better 
predictive factors of vitamin D3 status than the association between latitude and vitamin D3 
status (IARC, 2008). 
 
Epidemiological data and animal studies indicate that low blood serum vitamin D3 is linked 
to breast cancer, prostate cancer, colorectal cancer, non-Hodgkin’s lymphoma, multiple 
sclerosis, diabetes, bacterial infections, inflammatory bowel disease, elevated cholesterol, 
rheumatoid arthritis and common obesity (Holick, 2004; Garland et al, 2006; Foss, 2009). It 
has been estimated that the number of premature deaths from cancer due to insufficient 
vitamin D3 in the USA is up to 85,500 annually and up to 25,000 in the UK annually (Grant 
et al, 2005; PT, 2008). The associated cost in the USA for 2004 due to insufficient vitamin D3 
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has been estimated at $40 to $56 billion, whereas the costs of excess UV exposure were 
estimated at $6-7 billion (Grant et al, 2005). Vitamin D3 is also important for the prevention 
of rickets in children, osteoporosis, osteomalacia, and fractures in the elderly (Holick, 2004). 
The total direct cost related to fall injuries in the USA for people 65 and older in 2000 was 
more than $19 billion (Stevens et al, 2006) and is expected to rise to approximately $43.8 
billion by 2020 (Englander et al, 1996). More recent research has now shown that the related 
benefits of vitamin D3 are greater than previously known; consequently making the 
associated costs due to lack of sun exposure greater than once thought (Grant et al, 2007). 
 
Although over exposure to UV wavelengths are known to cause damage, vitamin D3 
synthesis occurs at doses far below those needed for erythema to arise (Webb, 1993). Small 
amounts of vitamin D3 can also be obtained from some foods, for example oily fish and eggs 
or by fortifying foods with vitamin D3. It has been shown that the vitamin D3 from these 
sources cannot provide sufficient vitamin D3 for the elderly (Mosekilde, 2005). Vitamin D3 
can also be obtained through vitamin tablets; however the simplest way to obtain vitamin D3 
is from moderate exposure to sunlight (Holick, 2004). Furthermore, this is also the cheapest 
way without the cost burden of vitamin tablets. 
 
At present, Australia and Canada are among very few countries that have guidelines on how 
much UV exposure the public should receive for vitamin D3 synthesis. The Australian 
guidelines suggest exposure to approximately 1/6 to 1/3 of a MED (minimum erythemal dose 
equivalent to approximately 34-67 Jm
-2
 of UV radiation), depending on age, that would be 
appropriate to provide adequate vitamin D3 levels (Samanek et al, 2006; CDHAA, 2004). 
Older people require more frequent exposures as vitamin D3 production rates are about 1/5-
1/4 for the elderly as for the young (Holick et al., 1989; MacLaughlin and Holick, 1985). 
Also, people with highly pigmented skin would require exposures 3-5 times greater than 
those necessary for fair skinned people (Harris, 2006; Pathak et al., 1999). Recent research 
suggests that the optimal serum vitamin D3 level for bone health and protection against other 
diseases is between 800 and 4000 IU per day (Aloia and Li-Ng, 2007; Lappe et al., 2007; 
Vieth et al., 2007; Dawson-Hughes et al., 2005; Giovannucci et al, 2006; Gorham et al, 2007; 
Garland et al, 2007; Rostand, 1997; Heaney et al, 2003). 1000 IU is equivalent to exposing 
15% (or the face, neck and hands) of the human body to approximately 1/3 MED (PS, 2006).  
 
A position statement was recently approved by the Working Group of the Australian and 
New Zealand Bone and Mineral Society, Endocrine Society, Osteoporosis Australia, 
Australian College of Dermatologists and the Cancer Council Australia recommending five 
minutes solar UV exposure either side of the peak UV periods on most days of the week in 
summer and approximately 2-3 hours solar UV exposure over a week in winter (PS, 2006). 
The Canadian Cancer Society has also recommended that people try to obtain 1000 IU of 
vitamin D3 (CCS, 2007). The Canadian Paediatric Society recommends that pregnant or 
breast-feeding women get 2,000 IU of vitamin D daily (DM, 2008). These recommendations 
are still behind emerging scientific findings (e.g. Giovannucci et al., 2006; Grant et al., 2007; 
Gorham et al., 2007; Garland et al., 2007). Nevertheless, they are still the most up to date 
statements that have been distributed to the public. These statements are also very generalized 
reports as sun exposure varies significantly with latitude and atmospheric conditions. 
 
Solar UV radiation is incident on the earth’s surface in two distinct components, direct and 
diffuse (or scattered). The direct component is straight forward to minimise by simply 
blocking its path, whereas the diffuse component is incident from all directions and is 
difficult to minimise. UV protection from direct UV (full sun) is very important and many 
strategies can be adopted to reduce overall UV exposure including the use of sunscreen, 
shade, hats and sunglasses. However, due to the phenomena of Rayleigh and Mie scattering 
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in the earth’s atmosphere, there is a significant proportion of the solar UV present in shade. 
Atmospheric scattering is influenced by factors such as solar zenith angle (SZA), clouds and 
atmospheric constituents play a major role in determining the relative proportions of UVA 
and UVB in diffuse UV, with greater scattering occurring at the shorter UVB wavelengths 
than at the longer wavelength UVA. Studies on the levels of UV observed in the shade of 
different shade environments have shown that the relative proportions of UVA and UVB in 
the shade are significantly different to those in full sun. The relative proportions are 
decreased for UVA and increased for UVB. Turnbull et al. (2005) found that UVA was 
reduced by as much as 65% when utilising a shade umbrella, whereas UVB exposures were 
only reduced by approximately 48%. Consequently, in the shade there is an increase in the 
relative proportion of the biologically effective wavelengths associated with pre-vitamin D3 
production in the body and a decrease in the total UV exposure compared to full sun.  
Currently, there is a major gap in knowledge in order to optimise the beneficial effects related 
to vitamin D3 effective wavelengths compared to reducing the biologically damaging 
overexposure to UV radiation. The goal of this research is to find a way to expose the human 
body to solar UV radiation that will maximise vitamin D3 synthesis and also minimise the 
risk of cancer (specifically skin cancer due to overexposure). The importance of this research 
is that it provides a basis for public health campaigns aimed at reducing the incidence of 
hypovitaminosis D and its attendant disorders, as well as reducing over exposure to harmful 
solar UV radiation. In the light of the considerable body of evidence regarding the harm done 
by excessive UV exposure and the public awareness of skin cancer, any new public health 
program would need to avoid confusing the public with seemingly opposing messages. 
Utilising diffuse solar UV radiation to obtain beneficial amounts of UV, while at the same 
time minimising personal overexposure to total UV radiation may prove to be absolutely 
necessary for an improvement in public health. Studies have shown that shade structures are 
important as a UV minimisation strategy; however, shade settings may also play an important 
role in providing exposures to the human body with adequate levels of UV radiation for 
vitamin D3 production without experiencing the higher levels of total UV experienced in full 
sun. The lengths of exposure to solar UV at noon in major Australian cities to produce 
exposures of 1/3 and 1/6 MED has previously been reported (Samanek et al., 2006). Shade as 
a protective device has been discussed numerous times before (e.g. Turnbull and Parisi, 2006) 
and it is not the aim of this research. This current research is about the exposures that humans 
may receive when utilising solar UV for vitamin D3 synthesis and the possible methods to 
optimise this radiation. The researchers are unaware of any similar research or attempts to 
show how solar UV exposures can be optimised so humans can receive adequate vitamin D3 
levels as well as reducing their total UV exposure. 
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Materials and Methods 
 
Global and diffuse UV spectra  
Global and diffuse solar UV spectral data from 280 to 400 nm in 0.5 nm steps have each been 
collected in ten minute intervals at Toowoomba (27.6
o
 S, 151.9
o
 E, 693 m above sea level), 
Australia. The period of data collection was in the Southern Hemisphere late spring and 
summer from 1 November 2006 to 28 February 2007. The minimum SZA in this period was 
4.1
o
. The spectroradiometer system is based on a double monochromator system model 
(DTM300, Bentham Instruments, Reading, UK) with the gratings having 2400 grooves/mm. 
The input and output slit widths on the monochromator of 0.37 mm have been selected to 
provide a bandwidth of 0.5 nm. The input optics are provided by a diffuser (model D6) with 
the manufacturer determined error associated with the cosine response as less than ±0.8% for 
a SZA up to 70
o
 and ±3.3% for an SZA of 80
o
. Wavelength and irradiance calibration of the 
spectral UV system was undertaken by employing the 365 nm mercury spectral line and a 
150 Watt quartz halogen lamp with calibration traceable to the National Physical Laboratory, 
UK standard.  
 
An automatic rotating shadow band (model RSB, Bentham Instruments, Reading, UK) that is 
0.015 m wide and 0.11 m above the spectroradiometer input optics was employed for the 
collection of the spectral diffuse UV data. This shadow band rotates into position to block the 
solar disc from the input optics for the collection of the diffuse UV spectrum and rotates to a 
position in the horizontal plane for the recording of the global UV spectrum. Control of the 
instrumentation is provided by the BenWin+ software (version 1.0.4.13, Bentham 
Instruments, Reading, UK). The software is configured to start scanning at 5:00 EST 
(Australian Eastern Standard Time), with the last scan for the day at 19:00 EST. The time 
taken to collect a spectrum from 280 to 400 nm is approximately one minute. The correction 
due to the shadow band has been determined according to the technique described by Rosales 
et al (2006). The values of the spectral irradiances at each 0.5 nm increment for each scan 
were multiplied by this correction factor. 
 
The amount of cloud cover at the time of each UV spectral scan was quantified by a Total 
Sky Imager (TSI) (model TSI-440, Yankee Environmental Systems, MA, USA) that is 
installed on the same building roof and several metres from the UV spectroradiometer. This 
instrument and associated software package allows determination of the fractional cloud 
cover at one minute intervals. The minimum and maximum values over the period of the total 
column ozone as obtained from the OMI satellite (OMI, 2007) on each day were 244 DU and 
311 DU with an average of 274 DU. 
 
 
Shade structures and latitudinal field measurements 
For this research, measurements were conducted beneath numerous shade structures (see 
appendix 1 to investigate the influence of a number of different factors, namely sky view, 
cloud cover and solar zenith angle. A portable spectrometer (model USB4000, Ocean Optics, 
USA) was employed to measure the solar UV radiation spectrum both outside and inside the 
shade as outlined in the following sections. The spectrometer was wavelength and irradiance 
calibrated following standard techniques against the Bentham spectroradiometer system 
(discussed above) for the summer and winter seasons. 
 
A range of different shade environments (at least ten shade environments) were utilised in 
this research. These shade environments included gazebos, verandas, shade umbrellas, trees, 
sides of buildings, doorways, etc. The shade environments were chosen so a range of 
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differently sized and shaped shade environments with different sky views could be 
investigated. 
 
Spectral UV field measurements were conducted at different latitudes to establish the effect 
that an increase or decrease in latitude has on vitamin D3 effective UV wavelengths in the 
shade (this information is currently unavailable and could not be obtained from radiative 
transfer models). Measurement sites were:  
Darwin (lat 12
o
 28’ S; long 130o 51’ E) 
Toowoomba  (lat 27
o 
36’ S; long 151o 54’ E) 
Canberra (lat 35
o
 18’ S; long 149o 08’ E) 
Hobart  (lat 42
o
 52’ S; long 147o 19’ E) 
London (lat 51
o
 30’ N; long 00o 05’ W) 
 
These measurements were necessary as solar UVB radiation levels decrease as the latitude 
increases and the extent that this affects exposures in the shade needs to be understood. 
Hence, this research assisted in providing a more complete picture of how diffuse UV 
exposure levels in the shade related to vitamin D3 synthesis varied for changing latitudes. The 
measurement protocol was the same as that stated previously. Spectral measurements were 
gathered throughout the day to account for the change in solar zenith angle. The measurement 
protocol consisted of measuring the full sun spectral irradiance for the horizontal and sun 
normal planes in full sun, followed by measurement of the spectral UV in the shade for the 
horizontal, 45
o
 and vertical planes (the 45
o
 and vertical measurements were directed to the 
north, south, east and west). Measurements in the shade were conducted at: different 
distances from the edge of the shade cast by the structure depending on the level of sky view 
being observed. Measurements were also conducted at various times throughout the year to 
account for seasonal changes in solar UV irradiances levels and atmospheric conditions. 
 
 
Human form measurements 
UV radiation dosimeters fabricated from polysulphone were placed at various locations (total 
of 29) across a life size manikin, which was used to model humans in both standing and 
sitting postures while in the centre of the shade and facing different directions. The use of 
manikins in the measurement of UV exposures has been validated and extensively employed 
(for example, Parisi et al., 2000a; 2000b; Turnbull and Parisi, 2005; Airey et al., 1995). The 
29 dosimeter sites on the manikin were located at: the vertex of the head, forehead, back of 
the head, nose, lips, chin, left cheek, left ear, right cheek, right ear, front of neck, back of 
neck, right side of neck, left side of neck, left shoulder, right shoulder, left forearm, right 
forearm, back of right hand, back of left hand, lower sternum, front of left thigh, front of right 
thigh, back of left thigh, back of right thigh, front of left shin, front of right shin, back of left 
shin and back of right shin. Manikins were exposed to UV radiation in the shade from 9:00 to 
12:00 EST for relatively clear sky conditions. Cumulative solar UV exposures outside the 
shade environment were quantified by a set of 18 dosimeters (one dosimeter removed every 
10 minutes of exposure) placed in full sun on a horizontal plane positioned near the shade 
environment. A series of measurements were conducted in Toowoomba in summer and 
winter to account for the variation in exposure levels, SZA and atmospheric conditions 
experienced during the different seasons. The exposure ratios, ER, were calculated according 
to the following equation: 
 
%100
FS
S
UV
UV
ER    (1) 
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where UVS is the UVD3 in the shade for a specific anatomical site and UVFS is the full sun 
UVD3 on a horizontal plane.  
 
 
Results and Discussion 
 
Global and diffuse spectral UV 
An example of diffuse and global UV spectra is shown in Figure 1 for a cloud free period on 
5 January 2007 for an SZA of (a) 5
o
 and (c) 50
o
. This illustrates the variation in the relative 
proportions of the different wavelengths when comparing diffuse UV to global UV. These 
spectral measurements were obtained using the spectral measurement system described 
earlier. For Figure 1a, the diffuse spectral irradiance summed over the UVA waveband was 
20.7 W/m
2
 compared to 68.4 W/m
2
 for the global UVA. Similarly, the diffuse UVB was 1.2 
W/m
2
 compared to 2.6 W/m
2
 for global UVB. For this specific date and time, the UVA was 
reduced by approximately 70% in the shade, whereas the UVB in the shade was only reduced 
by approximately 54%. Figure 1(b) and (d) provide the vitamin D3 biologically effective UV 
(UVD3) for the global and diffuse solar UV that has been calculated by weighting the spectra 
(from Figure 1a and c) with the pre-vitamin D3 (CIE, 2006) action spectrum. For Figure 1(b), 
the diffuse UVD3 irradiance was 0.36 W/m
2
 compared to 0.81 W/m
2
 for the global UVD3. For 
Figure 1d, the diffuse UVD3 irradiance was 0.13 W/m
2
 compared to 0.21 W/m
2
 for the global 
UVD3. For these specific weighted irradiances, UVD3 was reduced by approximately 56% for 
the smaller SZA, whereas the higher SZA UVD3 irradiance was only reduced by 
approximately 38% when comparing global and diffuse. Even though the reduction in diffuse 
UVD3 irradiance was lowest for the higher SZA (Figure 1d), the diffuse UVD3 measured at the 
smaller SZA (Figure 1b) was still nearly three times greater.  
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Figure 1. Global (thick) and diffuse (thin) UV spectra for a cloud free period on 5 January 
2007 for a SZA of approximately 5
o
 (a) and 50
o
 (c). The corresponding spectra weighted with 
the vitamin D3 action spectrum are shown in (b) and (d). 
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Variation in global and diffuse UV irradiance  
The variation in the UVD3 irradiances and the UVA for all sky conditions and a changing 
SZA are shown in Figure 2. Over 2,000 data points are provided in each figure for diffuse 
and global UV for a changing SZA and relatively clear sky conditions. For a SZA of 
approximately 5
o
, the observed maximum UVD3 irradiances were 0.80 W/m
2
 and 0.46 W/m
2
, 
for global and diffuse respectively. For the larger SZA of approximately 70
o
, maximum UVD3 
irradiances of 0.05 W/m
2
 and 0.04 W/m
2
 for global and diffuse were observed. For a SZA of 
approximately 5
o
, observed maximum UVA irradiances were 79.0 W/m
2
 and 36.2 W/m
2
, for 
global and diffuse respectively. For the larger SZA of approximately 70
o
, maximum UVA 
irradiances of 18.6 W/m
2
 and 12.9 W/m
2
 for global and diffuse were observed. The 
proportion of diffuse UV in global UV for UVD3 and for the UVA is illustrated in Figure 3 as 
a function of the SZA. Each data point is the average of the data up to 1
o
 either side of the 
respective data point (e.g. the 5
o
 data point is the average of all the values from 4
o
 to 6
o
). The 
error bars are ± one standard deviation of the data for each data point. The average difference 
(15% to 20%) between the proportions of diffuse in global were at a maximum for SZAs 
below approximately 55
o
.  
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Figure 2. Global and diffuse UV irradiances as a function of SZA related to UVD3 (a and b) 
and UVA (c and d) exposure. (Sourced from Turnbull and Parisi, 2008a). 
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Figure 3. Change in proportion of diffuse UV in global UV for the UVD3 (●) and the UVA 
(▲) irradiances. Errors bars provide the standard deviation of the data. (Sourced from 
Turnbull and Parisi, 2008a). 
 
 
The diffuse UV irradiances throughout the day for the two consecutive days of 12 December 
2006 (day 346) and 13 December 2006 (day 347) with the first being relatively cloud free and 
the second one being relatively cloudy are shown in Figure 4. For the first day, the cloud 
fraction was up to 0.4 for a total period of 30 minutes and less than 0.2 for the majority of the 
day. On the second day, the cloud fraction ranged from 1 to 0.1. The total column ozone from 
the OMI satellite (OMI, 2007) on each day is 276 DU and 272 DU respectively. The data is 
shown at 10 minute intervals, except for any small intervals where there was no data 
collected. The scatter of the global UV data is considerably higher on the cloudy day. The 
scattering of the diffuse UV data is slightly higher on the cloudy, but significantly less 
compared to the level of scattering seen in the global data.  
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Figure 4. Global (black) and diffuse (grey) UVD3 (a) and UVA (b) irradiances for relatively  
clear skies (left) and for changing cloud conditions (right). (Sourced from Turnbull and 
Parisi, 2008a). 
 
 
Ratio of UVD3 to UVA 
The average percentage ratios of UVD3 wavelengths compared to UVA wavelengths for 
diffuse and global UV are shown in Figure 5 for all sky conditions. For diffuse UV, the 
maximum ratio of UVD3 to UVA was 1.75% at a SZA of approximately 10
o
. The maximum 
ratio for global UV was 1.27% at 10
o
. The change in the average ratio of UVD3 to UVA with 
SZA is shown in Figure 6 for the global and diffuse UV. Each data point is the average of the 
data that is up to 1
o
 either side of the data point. The error bars are one standard deviation of 
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the data for each range. The maximum difference between the ratio of UVD3 wavelengths and 
the UVA wavelengths for global and diffuse UV occurs for SZAs of approximately 55
o
 and 
less. Therefore for SZAs of roughly 55
o
 and less, more UV radiation is contributed toward 
vitamin D3 synthesis than toward UVA exposure by utilising diffuse UV compared to global 
UV.  
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Figure 5. Ratio of UVD3 compared to UVA for global (a) and diffuse (b) as a function of 
SZA for all sky conditions. (Sourced from Turnbull and Parisi, 2008a). 
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Figure 6. Average ratios (expressed as percentages) of UVD3 to UVA for global (black) and 
diffuse (grey) UV as a function of SZA. Error bars denote the standard deviation of the data. 
(Sourced from Turnbull and Parisi, 2008a). 
 
 
Global, diffuse and shade exposures  
The variation in the UV irradiances for relatively clear sky conditions, changing latitude and 
a changing SZA are shown in Figure 7 for (a) UVD3 and (b) UVA. The error bars are ± one 
standard deviation of the data for each data point. For a SZA of approximately 5
o
, the average 
UVD3 irradiances were 0.67 W/m
2
 and 0.35 W/m
2
 for global and diffuse respectively. 
Whereas, average irradiances in the shade were 0.20 W/m
2
 and 0.11 W/m
2
, for a sky view 
greater than 40% and a sky view of less than 40% respectively. For the larger SZA of 
approximately 65
o
, average UVD3 irradiances were comparable for global, diffuse and shade 
at roughly 0.06 W/m
2
.  
 
For a SZA of approximately 5
o
, average UVA irradiances were 64.8 W/m
2
 and 24.5 W/m
2
, 
for global and diffuse respectively. Whereas, average irradiances in the shade were 12.2 
W/m
2
 and 5.0 W/m
2
, for a sky view greater than 40% and a sky view of less than 40% 
respectively. For the larger SZA of approximately 65
o
, average UVA irradiances of 16.5 
W/m
2
 and 12.7 W/m
2
 for global and diffuse were observed. Whereas, average irradiances in 
the shade were 8.5 W/m
2
 and 5.4 W/m
2
, for a sky view greater than 40% and a sky view of 
less than 40% respectively. The proportion of diffuse UV in global UV for UVD3 and for the 
UVA is illustrated in Figure 3 as a function of the SZA. Each data point is the average of the 
data up to 1
o
 either side of the respective data point (e.g. the 5
o
 data point is the average of all 
the values from 4
o
 to 6
o
). The error bars are ± one standard deviation of the data for each data 
point. The average difference (15% to 20%) between the proportions of diffuse in global 
were at a maximum for SZA’s below approximately 55o. 
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Figure 7. Variation between full sun (♦), diffuse (■) and shade (▲ for sky view  40% and ● 
for sky view  40%) for UVD3 (a) and UVA (b) irradiances during relatively clear sky 
conditions. Error bars denote the standard deviation of the data. 
 
 
Time required for exposure to reach approximately 66.7 J/m
2
 of UVD3 
The times required for an exposure equivalent to 66.7 J/m
2
 on a horizontal plane for a SZA 
greater than 4
o
 during 2007 are shown in Figure 8a for global UVD3 and Figure 8b for diffuse 
UVD3. 66.7 J/m
2
 of UVD3 is used here as the time needed for exposure to this amount of 
radiation is generally much shorter (e.g. Turnbull and Parisi, 2008b) than that needed for 1/3 
MED of exposure that the Australian guidelines recommend (Samanek et al, 2006; CDHAA, 
2004). This difference is due to the negligible response of the vitamin D3 action spectrum in 
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the UVA region above 330 nm, whereas the response of the erythemal action spectrum 
continues throughout the UVA waveband. Over 2,000 data points are provided in each figure 
for global and diffuse UVD3 for all SZA and clear sky conditions. The average times for an 
exposure equivalent to 66.7 J/m
2
 for vitamin D3 are shown in Table 1 for diffuse and global 
UV. For a SZA of 5
o
, the average time needed to receive an exposure of 66.7 J/m
2
 due to 
UVD3 was 1.7 and 3.2 minutes for global and diffuse respectively. Whereas, the average time 
needed to receive an equivalent exposure of 66.7 J/m
2
 for vitamin D3 in the shade (sky view 
greater than 40%) was approximately 5.7 minutes. However, for a SZA of 65
o
, the average 
time needed to receive an exposure of 66.7 J/m
2
 due to UVD3 was 19.1, 19.3 and 22.6 minutes 
for global, diffuse and shade respectively. These times are based on exposing 15% of the 
human body to UV radiation. Increasing the exposed body surface will subsequently decrease 
the time needed for vitamin D3 production (e.g. exposing three times more body surface will 
reduce the exposure times presented in this research by a factor of three). However, the time 
for 1/3 MED of erythemal effective UV will remain the same. Turnbull and Parisi (2008b) 
have shown that the time needed for 66.7 J/m
2 
of UVD3 and 1/3 MED is substantially 
different with times varying by roughly a factor of two for the smaller SZAs. Latitudinal 
measurements (from all sites) have been included in Figure 8b to illustrate the similarity of 
the shade observations to the diffuse observations.  
 
The smallest noon SZAs for summer for each site (Darwin 0
o
, Toowoomba 4
o
, Canberra 13
o
, 
Hobart 20
o
 and London 28
o
) are also included in the Figure 8(b) to illustrate where the 
respective exposure times for the different latitude sites lies. The largest noon SZAs for the 
middle of winter for each site are approximately: Darwin 26
o
, Toowoomba 50
o
, Canberra 58
o
, 
Hobart 66
o
 and London 74
o
. Cloud data is not included as previous research (Turnbull et al, 
2006; Turnbull and Parisi, 2008b) found that 1 to 7 okta of cloud cover has a considerably 
reduced effect on diffuse UV levels compared to global UV. Therefore, variations in cloud 
cover (below 8 okta) are far less likely to cause an obvious change in UVD3 exposure times in 
the shade; whereas global UVD3 exposure times will vary significantly depending on cloud 
cover and solar disc cover. 
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Figure 8. Time needed for exposure to (a) global and (b) diffuse UVD3 radiation that is 
equivalent to 66.7 J/m
2
. Combined latitudinal (■) from Darwin, Toowoomba, Canberra, 
Hobart and London is provided in Figure 8(b). Minimum noon SZAs for summer are also 
included for each site.  
 
Table 1. Average times for an exposure equivalent to 66.7 J/m
2
 of UVD3 radiation during 
2007 for clear sky conditions. The standard deviation of the data is provided in the 
parentheses.  
  Global UVD3 Diffuse UVD3 Shade UVD3  
SZA (min) (min) (min)  
5
o
 1.7 (0.3) 3.2 (0.3) 5.7 (1.0)  
15
o
 1.7 (0.2) 3.3 (0.4) 5.9 (1.1)  
25
o
 2.0 (0.4) 3.8 (0.4) 6.0 (1.0)  
35
o
 2.6 (0.4) 4.5 (0.5) 6.9 (2.6)  
45
o
 4.3 (0.9) 6.1 (0.6) 7.0 (1.7)  
55
o
 7.2 (1.4) 9.7 (1.0) 12.0 (2.9)  
65
o
 19.1 (8.6) 19.3 (2.7) 22.6 (5.6)  
75
o
 58.2 (56.7) 70.0 (10.7) N/A  
 
 
Vitamin D3 and total UV exposure 
Figure 9 illustrates the average total UV exposures received when exposing 15% of the 
human body to the equivalent of 66.7 J/m
2
 of UVD3 radiation. This was calculated by taking 
the average time to receive approximately 66.7 J/m
2
 of UVD3 for specific SZAs and summing 
the total UV irradiance over this time. This data is for relatively clear sky conditions and a 
changing SZA. The error bars denote ± one standard deviation of the data for each data point. 
For a SZA of 5
o
, the average total UV exposures were 6637.9 J/m
2
 and 4165.5 J/m
2
 for global 
and shade (sky view greater than 40%) respectively, which equates to an approximate 
reduction of 37% in total UV exposure. For the larger SZA of approximately 65
o
, average 
total UV exposures were 20178.7 J/m
2
 and 12141.5 J/m
2
 for global and shade (sky view 
greater than 40%) respectively, which equates to an approximate reduction of 40% in total 
17 
UV exposure. The largest variation between global and shade exposures was observed for a 
SZA of roughly 45
o
 with a 58% reduction in total UV exposure.  
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Figure 9. Total UV exposures received for global (♦) and shade - sky view greater than 40% 
(▲) when exposed to approximately 66.7 J/m
2
 of UVD3 radiation. Error bars denote the 
standard deviation of the data. 
 
 
Human form measurements 
The exposure ratios, ER, to each anatomical site are provided in Figure 10. Compared to full 
sun UVD3 exposures, the shade reduced exposures to the nose to approximately 38% and 63% 
of full sun exposures in summer and winter respectively. The shade was found to reduce 
exposures to the hands to roughly 47% and 51% of full sun exposures in summer and winter 
respectively. The largest variation in exposure ratios between the seasons was for the nose 
with a 25% decrease in exposure ratio from winter to summer. 
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Figure 10. UVD3 exposure ratios for specific anatomical sites for summer and winter. Error 
bars denote the standard deviation of the data. 
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Conclusions  
 
Studies on the levels of UV observed in the shade of different shade environments have 
shown that the relative proportions of UVA and UVB in the shade are significantly different 
to those in full sun (Turnbull et al., 2005; Turnbull and Parisi, 2003; Turnbull et al., 2003; 
Parisi et al., 2001). The relative proportions of the UVA in shade to those in full sun are 
decreased compared to the relative proportions of the UVB in shade to those in full sun. At 
certain latitudes and SZA, unprotected exposure for short periods to the UV under shade 
structures is the best course of action as it will contribute more toward vitamin D3 production 
than toward erythema compared to exposing the body to full sun UV due to the reduced 
relative component of the UVA in the shade.  
 
Humans need to be protected from damaging UV radiation, but they also need to be exposed 
to sub-erythemal solar UV so that vitamin D3 synthesis can occur. Research has shown that 
UVA plays a significant role in causing mutagenic and carcinogenic effects on human skin 
(Agar et al, 2004; Moan et al, 1999; Garland et al, 2003). Further research is also suggesting 
that increased UVA exposures and inadequately maintained vitamin D3 levels increases the 
chances of melanoma development (Godar et al., 2009). Therefore, reducing personal 
exposures to UVA radiation is essential. For a SZA of 55
o
 and less, more UV radiation is 
contributed toward vitamin D3 synthesis than toward UVA exposure by utilising diffuse UV 
compared to global UV. Therefore, this research indicates that a new approach to optimise 
UV exposure is to utilise diffuse UV in or around the middle of the day. Although the results 
were obtained at a sub-tropical site for 4 months over summer, they were collected for a 
range of SZA from approximately 5
o
 to 80
o
. This should allow extension to other latitudes 
and other seasons where these SZA are encountered.  
 
The influence of atmospheric ozone on solar UVD3 radiation increases with decreasing 
wavelength; as a result there is almost no influence of ozone at wavelengths greater than 320 
nm (Blumthaler, 1993). The influence of a decrease in atmospheric ozone is both the increase 
in the irradiances of the shorter wavelengths and a shift of the short wavelength cut-off to 
shorter wavelengths. This coincides with the higher effectiveness of the shorter wavelengths 
for biological change. Therefore, a reduction in ozone will cause a decrease in the exposure 
time necessary for vitamin D3 synthesis. Conversely, an increase in ozone levels will mean an 
increase in exposure time. Turnbull (2005) concluded that decreases in atmospheric ozone 
concentrations have an increasing effect on diffuse erythemal UV levels; however this is not 
to the same extent as for global erythemal UV. To what extent a change in ozone levels will 
affect vitamin D3 exposures in the shade is currently being determined. 
 
Nevertheless, the findings in this paper may have significant ramifications for future public 
health policy regarding sun exposure, which is currently being debated in many countries 
(Diffey, 2006; Gillie, 2006). Also, the findings of this research may prove useful to those that 
work from 9 am to 5 pm, where solar UV exposure at noon or during a lunch break may be 
the only option for the necessary UV exposures to initiate the synthesis of vitamin D3. 
Therefore, advice to stay out of the sun in the middle of the day, which is best for vitamin D3 
synthesis in the skin, can be adjusted to advocate the possible use of appropriate shade 
environments. This research shows that a specifically designed shade structure is not needed 
for vitamin D3 exposure. Any shade can be utilised to optimise UV exposure as long as you 
can see roughly 40% or more of the sky. Also, it is a huge misconception that a person can sit 
behind a closed window and still receive UVD3 radiation; as numerous studies have shown 
that window glass attenuates all UVD3 radiation. However, in the shade there is the potential 
danger due to the filtering of the infrared waveband, which may cause prolonged exposures. 
 
20 
Vitamin D3 deficiency, along with the problems associated with over exposure to UV is a 
worldwide problem. The position statement released by the Working Group of the Australian 
and New Zealand Bone and Mineral Society, Endocrine Society, Osteoporosis Australia, 
Australian College of Dermatologists and the Cancer Council Australia recommends a few 
minutes solar UV exposure either side of the peak UV periods on most days of the week in 
summer and approximately 2-3 hours solar UV exposure over a week in winter. Therefore, 
this position statement has the potential to be extended significantly by including new 
scientific findings and recommendations about UV in shade for different latitudes and this 
research provides strong scientific data to further improve these recommendations. 
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Appendix 1: Shade Environments 
The following are examples of the shaded environments used in this research. 
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